$KYMR
Kymera Therapeutics, Inc.

2021 Q1 Form 10-K Financial Statement

#000156459021012240 Filed on March 11, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2019 Q4
Revenue $18.70M $1.833M
YoY Change 445.57%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.910M $2.530M
YoY Change
% of Gross Profit
Research & Development $25.96M $11.09M
YoY Change 114.28%
% of Gross Profit
Depreciation & Amortization $485.0K $500.0K
YoY Change 25.32%
% of Gross Profit
Operating Expenses $31.87M $13.62M
YoY Change 117.18%
Operating Profit -$13.17M
YoY Change 17.09%
Interest Expense $90.00K $270.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net $94.00K
YoY Change -70.16%
Pretax Income -$13.08M -$11.51M
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$13.08M -$11.51M
YoY Change 19.6%
Net Earnings / Revenue -69.91% -628.1%
Basic Earnings Per Share
Diluted Earnings Per Share -$292.9K -$293.6K
COMMON SHARES
Basic Shares Outstanding 44.81M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $333.5M $91.96M
YoY Change
Cash & Equivalents $53.10M $76.02M
Short-Term Investments $280.4M $15.94M
Other Short-Term Assets $5.500M
YoY Change
Inventory
Prepaid Expenses
Receivables $900.0K
Other Receivables $800.0K
Total Short-Term Assets $340.8M $92.85M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $20.50M $3.794M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $101.6M
YoY Change
Other Assets $1.600M $1.774M
YoY Change
Total Long-Term Assets $123.8M $23.86M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $340.8M $92.85M
Total Long-Term Assets $123.8M $23.86M
Total Assets $464.6M $116.7M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.300M $3.276M
YoY Change
Accrued Expenses $13.00M $4.568M
YoY Change
Deferred Revenue $23.35M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $600.0K
YoY Change
Total Short-Term Liabilities $110.1M $34.57M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $500.0K
YoY Change
Other Long-Term Liabilities $92.00K
YoY Change
Total Long-Term Liabilities $92.00K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $110.1M $34.57M
Total Long-Term Liabilities $92.00K
Total Liabilities $189.3M $82.03M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$141.8M -$76.46M
YoY Change
Common Stock $417.1M $2.044M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $275.2M -$74.41M
YoY Change
Total Liabilities & Shareholders Equity $464.6M $116.7M
YoY Change

Cashflow Statement

Concept 2021 Q1 2019 Q4
OPERATING ACTIVITIES
Net Income -$13.08M -$11.51M
YoY Change 19.6%
Depreciation, Depletion And Amortization $485.0K $500.0K
YoY Change 25.32%
Cash From Operating Activities -$22.82M -$23.30M
YoY Change 89.29%
INVESTING ACTIVITIES
Capital Expenditures $164.0K -$400.0K
YoY Change -88.24%
Acquisitions
YoY Change
Other Investing Activities $44.50M -$16.00M
YoY Change
Cash From Investing Activities $44.32M -$16.40M
YoY Change -218.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 595.0K 21.00M
YoY Change -99.36%
NET CHANGE
Cash From Operating Activities -22.82M -23.30M
Cash From Investing Activities 44.32M -16.40M
Cash From Financing Activities 595.0K 21.00M
Net Change In Cash 22.10M -18.70M
YoY Change -49.39%
FREE CASH FLOW
Cash From Operating Activities -$22.82M -$23.30M
Capital Expenditures $164.0K -$400.0K
Free Cash Flow -$22.99M -$22.90M
YoY Change 70.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10841000
CY2020 dei Entity Registrant Name
EntityRegistrantName
Kymera Therapeutics, Inc.
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001815442
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44811485
CY2020Q2 dei Entity Public Float
EntityPublicFloat
0
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity File Number
EntityFileNumber
001-39460
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2992166
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
200 Arsenal Yards Blvd
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
CY2020 dei City Area Code
CityAreaCode
857
CY2020 dei Local Phone Number
LocalPhoneNumber
285-5300
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31004000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76015000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
265198000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
15942000
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
577000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
856000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
888000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
92845000
CY2019Q4 us-gaap Assets
Assets
116702000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
110617000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
77838000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14128000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
604000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
100000
CY2020Q4 us-gaap Liabilities
Liabilities
203287000
CY2019Q4 us-gaap Liabilities
Liabilities
82028000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
412777000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2044000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128765000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-76456000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-128000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4704000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
302339000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
162531000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3794000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18289000
CY2020 dei Trading Symbol
TradingSymbol
KYMR
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1589000
CY2020Q4 us-gaap Assets
Assets
487175000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4368000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10330000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
92552000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2572000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
689000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
106000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9845000
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1774000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3276000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4568000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
23349000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2696000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
681000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34570000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
29642000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16651000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1165000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-46304000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-42205000
CY2019 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1005000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
283888000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-74406000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
487175000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
116702000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44592288
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2208982
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44482186
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1929516
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34034000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2934000
CY2020 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
kymr:CollaborationRevenueFromRelatedPartyMember
CY2019 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
kymr:CollaborationRevenueFromRelatedPartyMember
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
62105000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37158000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18233000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7981000
CY2020 us-gaap Operating Expenses
OperatingExpenses
80338000
CY2019 us-gaap Operating Expenses
OperatingExpenses
45139000
CY2020 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
826000
CY2020 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
115000
CY2019 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
46000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
711000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
959000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-45593000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-41246000
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-134000
CY2019 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
6000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45727000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41240000
CY2020 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
9050000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-54643000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41246000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.15
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-24.28
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17349582
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1698522
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17003000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-34436000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
74000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1196000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000
CY2020 kymr Exchange Of Convertible Preferred Stock Impact On Equity
ExchangeOfConvertiblePreferredStockImpactOnEquity
-9050000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
162000
CY2020 kymr Stock Issued During Period Value Restricted Stock Vested
StockIssuedDuringPeriodValueRestrictedStockVested
112000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5190000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-134000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
211332000
CY2020 us-gaap Profit Loss
ProfitLoss
-45593000
CY2019 us-gaap Profit Loss
ProfitLoss
-41246000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
5190000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
1196000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17905000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9096000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
532000
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
529382000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-422588000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16486000
CY2019 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
15954000
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
115890000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1763000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
825000
CY2020 kymr Non Cash Research And Development Expense
NonCashResearchAndDevelopmentExpense
332000
CY2019 kymr Non Cash Research And Development Expense
NonCashResearchAndDevelopmentExpense
443000
CY2020 kymr Net Amortization Of Premiums And Discounts On Investments
NetAmortizationOfPremiumsAndDiscountsOnInvestments
-1571000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3816000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
564000
CY2020 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
577000
CY2020 kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
856000
CY2019 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-148000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
990000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
904000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5754000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2248000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
117400000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
52991000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
30000
CY2020 kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-8444000
CY2019 kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-1350000
CY2020 kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2647000
CY2019 kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-383000
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
205000
CY2019 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-7000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
88130000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
162000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
74000
CY2020 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
554000
CY2019 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
371000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
183146000
CY2020 kymr Proceeds From Concurrent Private Placement
ProceedsFromConcurrentPrivatePlacement
13527000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
289262000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34911000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-45196000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36330000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
77789000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41459000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32593000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
115000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
46000
CY2019 kymr Purchases Of Property And Equipment Through Finance And Lease Liabilities
PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities
1642000
CY2020 kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
27000
CY2019 kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
315000
CY2020 kymr Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
397000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
16522000
CY2019 kymr Tenant Improvement Receivable Included In Other Assets
TenantImprovementReceivableIncludedInOtherAssets
287000
CY2020 kymr Reduction Of Right Of Use Asset And Liability Due To Lease Modification
ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification
2161000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
1589000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
1774000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amounts of expenses during the reporting period. Management&#8217;s estimates and judgments are derived and continually evaluated based on available information, historical experience and various other assumptions that are believed to be reasonable under the circumstances. Because the use of estimates is inherent in the financial reporting process, actual results could differ from those estimates. In recording transactions and balances resulting from business operations, management makes estimates based on the best information available at the time the estimate is made. Significant estimates relied upon in preparing these financial statements include revenue recognized under our collaboration agreement with Sanofi and Vertex, accrual for research and development expenses, equity-based compensation expense, and the valuation of equity. As better information becomes available or actual amounts are determinable, the recorded estimates are revised. Consequently, operating results can be affected by revisions to prior estimates.</p>
CY2020Q4 us-gaap Investments And Cash
InvestmentsAndCash
458700000
CY2020 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On August 20, 2020, the Board approved a 1-for-1.5949 reverse stock split of the Company’s issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each of the Company’s outstanding series of preferred stock. All share and per share amounts in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to this reverse stock split, including reclassifying an amount equal to the reduction in par value of common stock to additional paid-in capital.
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.5949
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P1Y
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2019 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
400000
CY2019Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2019Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2020Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2019Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2020Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2019Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2020Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2019Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
427863000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
134000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
427729000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
15936000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
15942000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
0
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
65
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
392200000
CY2020 kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
48
CY2020Q4 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
295600000
CY2020 kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
25
CY2020 kymr Number Of Marketable Securities Sold
NumberOfMarketableSecuritiesSold
1
CY2019 us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
CY2020 kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
65
CY2020 kymr Contract With Customer Asset Net Additions
ContractWithCustomerAssetNetAdditions
152010000
CY2020 kymr Contract With Customer Asset Net Deductions
ContractWithCustomerAssetNetDeductions
-150577000
CY2020Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
1433000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
52991000
CY2020 kymr Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
151433000
CY2020 kymr Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
-34034000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
170390000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12988000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4843000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2147000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1049000
CY2020 us-gaap Depreciation
Depreciation
1800000
CY2019 us-gaap Depreciation
Depreciation
900000
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
716000
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
385000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
2719000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
1597000
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
121000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
46000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
621000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
340000
CY2020 us-gaap Lease Cost
LeaseCost
4177000
CY2019 us-gaap Lease Cost
LeaseCost
2368000
CY2020 kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
-3024000
CY2019 kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
635000
CY2020 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
587000
CY2019 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
46000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
121000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
385000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y3M18D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y3M18D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.103
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.080
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.078
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2691000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2581000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2659000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2732000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2814000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
12925000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
26402000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9702000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
16700000
CY2020Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
712000
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
459000
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
245000
CY2020Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1416000
CY2020Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
123000
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
1293000
CY2020Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
5821000
CY2019Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
2617000
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2918000
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1256000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1585000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
606000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
89000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M2D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M26D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.71
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.005
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0183
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5190000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1196000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.058
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.070
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.009
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.006
CY2020 kymr Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.000
CY2019 kymr Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.036
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.020
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.007
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.288
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.294
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
15621000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
15011000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
3866000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
4319000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3757000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1637000
CY2020Q4 kymr Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
4563000
CY2019Q4 kymr Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
5286000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
10313000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
1589000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
525000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
39709000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
26778000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
34075000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20949000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5634000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5829000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
1506000
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
754000
CY2020Q4 kymr Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
4128000
CY2019Q4 kymr Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
5075000
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
34100000
CY2019Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
20900000
CY2020 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
13100000
CY2020 kymr Federal Net Operating Loss Carryovers Not Subject To Expiration
FederalNetOperatingLossCarryoversNotSubjectToExpiration
64600000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2019 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1691028
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25503512

Files In Submission

Name View Source Status
0001564590-21-012240-index-headers.html Edgar Link pending
0001564590-21-012240-index.html Edgar Link pending
0001564590-21-012240.txt Edgar Link pending
0001564590-21-012240-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g23ode3tb50n000001.jpg Edgar Link pending
g23ode3tb50n000002.jpg Edgar Link pending
g23ode3tb50n000003.jpg Edgar Link pending
g23ode3tb50n000004.jpg Edgar Link pending
g23ode3tb50n000005.jpg Edgar Link pending
g23ode3tb50n000006.jpg Edgar Link pending
g23ode3tb50n000007.jpg Edgar Link pending
g23ode3tb50n000008.jpg Edgar Link pending
g23ode3tb50n000009.jpg Edgar Link pending
g23ode3tb50n000010.jpg Edgar Link pending
g23ode3tb50n000011.jpg Edgar Link pending
g23ode3tb50n000012.jpg Edgar Link pending
g23ode3tb50n000013.jpg Edgar Link pending
g23ode3tb50n000014.jpg Edgar Link pending
g23ode3tb50n000015.jpg Edgar Link pending
g23ode3tb50n000016.jpg Edgar Link pending
g23ode3tb50n000017.jpg Edgar Link pending
g23ode3tb50n000018.jpg Edgar Link pending
g23ode3tb50n000019.jpg Edgar Link pending
g23ode3tb50n000020.jpg Edgar Link pending
g23ode3tb50n000021.jpg Edgar Link pending
g23ode3tb50n000022.jpg Edgar Link pending
g23ode3tb50n000023.jpg Edgar Link pending
g23ode3tb50n000024.jpg Edgar Link pending
g23ode3tb50n000025.jpg Edgar Link pending
g23ode3tb50n000026.jpg Edgar Link pending
g23ode3tb50n000027.jpg Edgar Link pending
g23ode3tb50n000028.jpg Edgar Link pending
g23ode3tb50n000029.jpg Edgar Link pending
g23ode3tb50n000030.jpg Edgar Link pending
g23ode3tb50n000031.jpg Edgar Link pending
g23ode3tb50n000032.jpg Edgar Link pending
g23ode3tb50n000033.jpg Edgar Link pending
g23ode3tb50n000034.jpg Edgar Link pending
kymr-10k_20201231.htm Edgar Link pending
kymr-20201231.xml Edgar Link completed
kymr-20201231.xsd Edgar Link pending
kymr-20201231_cal.xml Edgar Link unprocessable
kymr-20201231_def.xml Edgar Link unprocessable
kymr-20201231_lab.xml Edgar Link unprocessable
kymr-20201231_pre.xml Edgar Link unprocessable
kymr-ex211_1388.htm Edgar Link pending
kymr-ex231_895.htm Edgar Link pending
kymr-ex311_11.htm Edgar Link pending
kymr-ex312_10.htm Edgar Link pending
kymr-ex321_9.htm Edgar Link pending
kymr-ex322_8.htm Edgar Link pending
kymr-ex43_735.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending